GGrantIndex
← Search

OBI-1 - 302 Pivotal study, acquired hemophilia, all bleeding categories

$0R44FY2005HLNIH

Octagen Corporation, Blue Bell PA

Investigators

Garrett E Bergman
View original record on NIH RePORTER →
OBI-1 - 302 Pivotal study, acquired hemophilia, all bleeding categories · GrantIndex